Alexandria Co. For Pharmaceuticals & Chemical Industries Stock
Equities
AXPH
EGS38341C011
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
210.7 EGP | 0.00% |
|
0.00% | +18.20% |
Sales 2022 | 1.22B 25.38M | Sales 2023 | 1.48B 30.96M | Capitalization | 691M 14.41M |
---|---|---|---|---|---|
Net income 2022 | 129M 2.69M | Net income 2023 | 126M 2.63M | EV / Sales 2022 | 0.32 x |
Net cash position 2022 | 145M 3.02M | Net cash position 2023 | 78.48M 1.64M | EV / Sales 2023 | 0.41 x |
P/E ratio 2022 |
4.1
x | P/E ratio 2023 |
5.47
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
9.41% | Free-Float | 19.62% |
1 month | -3.71% | ||
3 months | -6.77% | ||
6 months | +7.63% | ||
Current year | +18.20% |
![Extreme 213.52](/images/extremecours_fleche.png)
![Extreme 209.05](/images/extremecours_fleche.png)
![Extreme 178.5](/images/extremecours_fleche.png)
![Extreme 120](/images/extremecours_fleche.png)
![Extreme 85](/images/extremecours_fleche.png)
![Extreme 85](/images/extremecours_fleche.png)
![Extreme 42.3](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - | |
Ahmed Fuad
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Director/Board Member | - | - | |
Chief Executive Officer | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-10 | 210.7 | 0.00% | 98 |
24-07-09 | 210.7 | 0.00% | 316 |
24-07-08 | 210.7 | 0.00% | 241 |
24-07-07 | 210.7 | 0.00% | 745 |
24-07-04 | 210.7 | 0.00% | 169 |
End-of-day quote Egyptian Exchange, July 09, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.20% | 21.95M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- AXPH Stock